FF:11887-125D6: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity= | |sample_ethnicity= | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;5.77531888713258e-257!GO:0005737;cytoplasm;2.68679506871389e-130!GO:0043227;membrane-bound organelle;6.72566596763532e-129!GO:0043231;intracellular membrane-bound organelle;1.51993240013929e-128!GO:0043226;organelle;3.65289055557698e-119!GO:0043229;intracellular organelle;2.40626143268459e-118!GO:0044444;cytoplasmic part;2.22640926261565e-87!GO:0044422;organelle part;2.31139219646976e-75!GO:0044446;intracellular organelle part;1.01047361857133e-73!GO:0044237;cellular metabolic process;9.83599492083908e-70!GO:0044238;primary metabolic process;7.61072853754815e-68!GO:0005515;protein binding;8.9535404573209e-68!GO:0043170;macromolecule metabolic process;1.31591146240516e-66!GO:0032991;macromolecular complex;1.07722992510055e-64!GO:0003723;RNA binding;2.02598056824635e-59!GO:0030529;ribonucleoprotein complex;4.5421157893349e-59!GO:0005634;nucleus;7.24664917272153e-54!GO:0044428;nuclear part;1.63149960226798e-52!GO:0019538;protein metabolic process;9.59103654356785e-48!GO:0033036;macromolecule localization;7.98787583549189e-45!GO:0006412;translation;1.08166762892018e-44!GO:0044267;cellular protein metabolic process;1.08166762892018e-44!GO:0044260;cellular macromolecule metabolic process;1.70692480757698e-44!GO:0043233;organelle lumen;1.35593578488885e-43!GO:0031974;membrane-enclosed lumen;1.35593578488885e-43!GO:0045184;establishment of protein localization;2.09093860472081e-43!GO:0015031;protein transport;2.09093860472081e-43!GO:0008104;protein localization;1.3170276013101e-41!GO:0005829;cytosol;3.03715829886372e-38!GO:0043283;biopolymer metabolic process;3.24958297778316e-37!GO:0010467;gene expression;5.30016558859128e-37!GO:0006396;RNA processing;2.20936630666167e-36!GO:0016071;mRNA metabolic process;2.08063672229462e-34!GO:0031090;organelle membrane;3.07157924546358e-34!GO:0031981;nuclear lumen;1.84256808994468e-33!GO:0009059;macromolecule biosynthetic process;1.88447800581427e-33!GO:0008380;RNA splicing;1.35802979850157e-31!GO:0043234;protein complex;1.52895309176652e-31!GO:0005739;mitochondrion;2.26363042146034e-31!GO:0044249;cellular biosynthetic process;2.47834127664443e-31!GO:0009058;biosynthetic process;2.80925313108556e-31!GO:0005840;ribosome;5.12557364148052e-31!GO:0006915;apoptosis;8.67982087173236e-31!GO:0012501;programmed cell death;1.1604566467772e-30!GO:0006397;mRNA processing;2.69709695216214e-30!GO:0046907;intracellular transport;1.75715882490017e-29!GO:0008219;cell death;5.13751724981915e-29!GO:0016265;death;5.13751724981915e-29!GO:0006886;intracellular protein transport;5.4058139005897e-29!GO:0003735;structural constituent of ribosome;1.03791698698426e-28!GO:0016043;cellular component organization and biogenesis;7.2929083597737e-28!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;4.9833998064952e-27!GO:0031967;organelle envelope;7.5666677744119e-27!GO:0031975;envelope;1.47107667735223e-26!GO:0033279;ribosomal subunit;1.48265009297004e-26!GO:0005830;cytosolic ribosome (sensu Eukaryota);6.21191505909323e-25!GO:0044445;cytosolic part;1.35211802790451e-23!GO:0005681;spliceosome;1.59101520172252e-23!GO:0005654;nucleoplasm;2.57011338233721e-23!GO:0044429;mitochondrial part;3.80631885403802e-23!GO:0051649;establishment of cellular localization;1.0478932459406e-22!GO:0065003;macromolecular complex assembly;3.43942918987388e-22!GO:0051641;cellular localization;5.04618884769187e-22!GO:0022613;ribonucleoprotein complex biogenesis and assembly;5.01854958657929e-21!GO:0042981;regulation of apoptosis;7.85483127310245e-20!GO:0043067;regulation of programmed cell death;1.56187264394953e-19!GO:0044451;nucleoplasm part;2.65401645592537e-19!GO:0000166;nucleotide binding;7.71188270594202e-19!GO:0006119;oxidative phosphorylation;1.26119733116115e-18!GO:0022607;cellular component assembly;2.11076522666416e-18!GO:0008134;transcription factor binding;2.84965201529679e-18!GO:0044265;cellular macromolecule catabolic process;6.37932630549384e-18!GO:0016192;vesicle-mediated transport;7.64642006578846e-18!GO:0005740;mitochondrial envelope;2.20070262687659e-17!GO:0006512;ubiquitin cycle;3.24093656545807e-17!GO:0022618;protein-RNA complex assembly;3.61781550560249e-17!GO:0003676;nucleic acid binding;4.44533539074172e-17!GO:0048770;pigment granule;7.53510416926414e-17!GO:0042470;melanosome;7.53510416926414e-17!GO:0019866;organelle inner membrane;8.91988785772661e-17!GO:0031966;mitochondrial membrane;9.18354260256619e-17!GO:0016070;RNA metabolic process;2.38471289733861e-16!GO:0007243;protein kinase cascade;2.60693899612453e-16!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;3.61206011142053e-16!GO:0016462;pyrophosphatase activity;3.87943451406341e-16!GO:0043285;biopolymer catabolic process;4.18357911188061e-16!GO:0016817;hydrolase activity, acting on acid anhydrides;5.43211189047953e-16!GO:0017111;nucleoside-triphosphatase activity;6.48576409956056e-16!GO:0043412;biopolymer modification;9.98184722383125e-16!GO:0019941;modification-dependent protein catabolic process;1.3209347655993e-15!GO:0043632;modification-dependent macromolecule catabolic process;1.3209347655993e-15!GO:0051603;proteolysis involved in cellular protein catabolic process;1.5801823496806e-15!GO:0044257;cellular protein catabolic process;1.71773048771553e-15!GO:0006511;ubiquitin-dependent protein catabolic process;2.14067676866435e-15!GO:0006605;protein targeting;7.20125693157645e-15!GO:0016604;nuclear body;7.20125693157645e-15!GO:0009057;macromolecule catabolic process;1.15614127382072e-14!GO:0007249;I-kappaB kinase/NF-kappaB cascade;1.2172676476946e-14!GO:0048523;negative regulation of cellular process;1.2172676476946e-14!GO:0006464;protein modification process;1.85389748128457e-14!GO:0005773;vacuole;2.19214550632047e-14!GO:0000502;proteasome complex (sensu Eukaryota);2.2938049541746e-14!GO:0015934;large ribosomal subunit;2.32946631418832e-14!GO:0005743;mitochondrial inner membrane;4.79747241129826e-14!GO:0044248;cellular catabolic process;4.9790380586973e-14!GO:0006996;organelle organization and biogenesis;6.15112230832452e-14!GO:0016874;ligase activity;7.22013806990277e-14!GO:0044455;mitochondrial membrane part;9.12796438189873e-14!GO:0043687;post-translational protein modification;1.20867955989874e-13!GO:0050794;regulation of cellular process;1.26633270065031e-13!GO:0032553;ribonucleotide binding;1.75074888248206e-13!GO:0032555;purine ribonucleotide binding;1.75074888248206e-13!GO:0008135;translation factor activity, nucleic acid binding;2.54041257692629e-13!GO:0016607;nuclear speck;2.82957854960025e-13!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);3.08529107614664e-13!GO:0006913;nucleocytoplasmic transport;3.94764678445259e-13!GO:0007242;intracellular signaling cascade;3.95852626086101e-13!GO:0030163;protein catabolic process;4.48420288589372e-13!GO:0015935;small ribosomal subunit;4.49346354985572e-13!GO:0048519;negative regulation of biological process;5.15484980027016e-13!GO:0043069;negative regulation of programmed cell death;5.47514808223952e-13!GO:0043066;negative regulation of apoptosis;6.50164552806748e-13!GO:0017076;purine nucleotide binding;6.91809522063487e-13!GO:0051169;nuclear transport;7.50190804584182e-13!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;9.17686087045461e-13!GO:0000323;lytic vacuole;9.84165961755822e-13!GO:0005764;lysosome;9.84165961755822e-13!GO:0006457;protein folding;9.89466313008631e-13!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);1.47607221633381e-12!GO:0012505;endomembrane system;2.82906081513374e-12!GO:0006413;translational initiation;5.6616021104598e-12!GO:0003743;translation initiation factor activity;5.87902439930998e-12!GO:0005794;Golgi apparatus;9.45040717746273e-12!GO:0051246;regulation of protein metabolic process;1.21211695403045e-11!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;1.23163991964077e-11!GO:0006259;DNA metabolic process;1.35505863371645e-11!GO:0005768;endosome;1.53960419981235e-11!GO:0003712;transcription cofactor activity;1.93652876795759e-11!GO:0065009;regulation of a molecular function;2.09341073038161e-11!GO:0006950;response to stress;3.37576755494397e-11!GO:0006793;phosphorus metabolic process;4.34176379154308e-11!GO:0006796;phosphate metabolic process;4.34176379154308e-11!GO:0051186;cofactor metabolic process;4.97721396641052e-11!GO:0005746;mitochondrial respiratory chain;5.06054454468433e-11!GO:0006446;regulation of translational initiation;5.86557860112615e-11!GO:0051082;unfolded protein binding;7.28022443894388e-11!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;1.3938259781186e-10!GO:0050789;regulation of biological process;1.51950284354434e-10!GO:0005730;nucleolus;1.64905767146785e-10!GO:0002376;immune system process;1.86005734029857e-10!GO:0006916;anti-apoptosis;2.1594629520098e-10!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;2.77455939950352e-10!GO:0048193;Golgi vesicle transport;2.9738110724985e-10!GO:0050136;NADH dehydrogenase (quinone) activity;3.30365499416465e-10!GO:0003954;NADH dehydrogenase activity;3.30365499416465e-10!GO:0008137;NADH dehydrogenase (ubiquinone) activity;3.30365499416465e-10!GO:0000398;nuclear mRNA splicing, via spliceosome;3.48153240324722e-10!GO:0000375;RNA splicing, via transesterification reactions;3.48153240324722e-10!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;3.48153240324722e-10!GO:0006366;transcription from RNA polymerase II promoter;3.90895897413219e-10!GO:0006732;coenzyme metabolic process;4.97304485115263e-10!GO:0016310;phosphorylation;8.63560216094277e-10!GO:0016787;hydrolase activity;1.056296092362e-09!GO:0019829;cation-transporting ATPase activity;1.1529665860714e-09!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.28125019212343e-09!GO:0005635;nuclear envelope;1.54062926763988e-09!GO:0005524;ATP binding;2.15778549689701e-09!GO:0017038;protein import;2.56486742897335e-09!GO:0008639;small protein conjugating enzyme activity;2.80354889826944e-09!GO:0009056;catabolic process;3.0476341102396e-09!GO:0015986;ATP synthesis coupled proton transport;3.05534918739173e-09!GO:0015985;energy coupled proton transport, down electrochemical gradient;3.05534918739173e-09!GO:0032559;adenyl ribonucleotide binding;3.87848800577621e-09!GO:0048522;positive regulation of cellular process;4.75050413102323e-09!GO:0019787;small conjugating protein ligase activity;4.9208969733507e-09!GO:0031324;negative regulation of cellular metabolic process;4.94422535789963e-09!GO:0004842;ubiquitin-protein ligase activity;4.97544996833011e-09!GO:0007049;cell cycle;4.97544996833011e-09!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;5.00670521800666e-09!GO:0065007;biological regulation;5.00710743334308e-09!GO:0042775;organelle ATP synthesis coupled electron transport;6.96292796512746e-09!GO:0042773;ATP synthesis coupled electron transport;6.96292796512746e-09!GO:0009967;positive regulation of signal transduction;1.10812058767922e-08!GO:0044453;nuclear membrane part;1.14217646748151e-08!GO:0030964;NADH dehydrogenase complex (quinone);1.16055270943854e-08!GO:0045271;respiratory chain complex I;1.16055270943854e-08!GO:0005747;mitochondrial respiratory chain complex I;1.16055270943854e-08!GO:0006163;purine nucleotide metabolic process;1.19497099294176e-08!GO:0005770;late endosome;1.28412113422991e-08!GO:0009615;response to virus;1.28529872136228e-08!GO:0006164;purine nucleotide biosynthetic process;1.31090200032257e-08!GO:0006417;regulation of translation;1.31225700310463e-08!GO:0009150;purine ribonucleotide metabolic process;1.42997035956541e-08!GO:0030554;adenyl nucleotide binding;1.43036731865417e-08!GO:0009152;purine ribonucleotide biosynthetic process;1.43442715282754e-08!GO:0042623;ATPase activity, coupled;1.46801287028213e-08!GO:0006955;immune response;1.57172707160157e-08!GO:0009055;electron carrier activity;1.81890544906774e-08!GO:0005783;endoplasmic reticulum;2.15960138544675e-08!GO:0016887;ATPase activity;2.20721420389794e-08!GO:0051170;nuclear import;2.325859882913e-08!GO:0009259;ribonucleotide metabolic process;2.61731048438277e-08!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;2.65196396002505e-08!GO:0031965;nuclear membrane;2.89125659099885e-08!GO:0043228;non-membrane-bound organelle;3.04712777918843e-08!GO:0043232;intracellular non-membrane-bound organelle;3.04712777918843e-08!GO:0043065;positive regulation of apoptosis;3.17899818015621e-08!GO:0048518;positive regulation of biological process;3.77811646639991e-08!GO:0008565;protein transporter activity;3.93856796179409e-08!GO:0006754;ATP biosynthetic process;4.01843355515206e-08!GO:0006753;nucleoside phosphate metabolic process;4.01843355515206e-08!GO:0015078;hydrogen ion transmembrane transporter activity;4.13924133921897e-08!GO:0050790;regulation of catalytic activity;4.24447150377052e-08!GO:0043068;positive regulation of programmed cell death;4.27261600826952e-08!GO:0006606;protein import into nucleus;6.01498110899404e-08!GO:0016469;proton-transporting two-sector ATPase complex;6.1441906832514e-08!GO:0009260;ribonucleotide biosynthetic process;6.14570800108732e-08!GO:0016879;ligase activity, forming carbon-nitrogen bonds;7.40809831767333e-08!GO:0016881;acid-amino acid ligase activity;8.39386217355174e-08!GO:0009892;negative regulation of metabolic process;1.15890507119815e-07!GO:0050657;nucleic acid transport;1.15890507119815e-07!GO:0051236;establishment of RNA localization;1.15890507119815e-07!GO:0050658;RNA transport;1.15890507119815e-07!GO:0051726;regulation of cell cycle;1.16953397978841e-07!GO:0000074;regulation of progression through cell cycle;1.60498081144923e-07!GO:0006403;RNA localization;1.60600769820549e-07!GO:0031980;mitochondrial lumen;1.63505908609403e-07!GO:0005759;mitochondrial matrix;1.63505908609403e-07!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.68235876265036e-07!GO:0005774;vacuolar membrane;1.69715259546134e-07!GO:0019222;regulation of metabolic process;1.75206098741268e-07!GO:0046034;ATP metabolic process;1.75206098741268e-07!GO:0009889;regulation of biosynthetic process;1.76384746942609e-07!GO:0003924;GTPase activity;1.79293053604736e-07!GO:0003713;transcription coactivator activity;1.81959568642365e-07!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;1.87245311855353e-07!GO:0009145;purine nucleoside triphosphate biosynthetic process;1.87245311855353e-07!GO:0008047;enzyme activator activity;2.1101190926575e-07!GO:0009142;nucleoside triphosphate biosynthetic process;2.4870327903676e-07!GO:0009201;ribonucleoside triphosphate biosynthetic process;2.4870327903676e-07!GO:0005525;GTP binding;2.84715799264266e-07!GO:0019899;enzyme binding;2.93279554865333e-07!GO:0016481;negative regulation of transcription;3.02654689565124e-07!GO:0031326;regulation of cellular biosynthetic process;3.10865133484727e-07!GO:0009607;response to biotic stimulus;3.86382693822374e-07!GO:0009205;purine ribonucleoside triphosphate metabolic process;3.98266700724198e-07!GO:0009144;purine nucleoside triphosphate metabolic process;3.98266700724198e-07!GO:0016564;transcription repressor activity;4.35416280691481e-07!GO:0006917;induction of apoptosis;4.67694411777513e-07!GO:0048468;cell development;4.85428782377994e-07!GO:0005643;nuclear pore;4.9098361574092e-07!GO:0009199;ribonucleoside triphosphate metabolic process;4.9098361574092e-07!GO:0045786;negative regulation of progression through cell cycle;5.07116858674262e-07!GO:0006752;group transfer coenzyme metabolic process;5.07290051689403e-07!GO:0006974;response to DNA damage stimulus;5.94436460946422e-07!GO:0006461;protein complex assembly;6.20303478710108e-07!GO:0012502;induction of programmed cell death;6.20303478710108e-07!GO:0051188;cofactor biosynthetic process;6.25367568929523e-07!GO:0009108;coenzyme biosynthetic process;6.34472999224139e-07!GO:0044437;vacuolar part;8.53386657170156e-07!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;8.6978690436605e-07!GO:0009141;nucleoside triphosphate metabolic process;8.73395025631275e-07!GO:0005839;proteasome core complex (sensu Eukaryota);8.77848826372636e-07!GO:0005765;lysosomal membrane;1.19436318694217e-06!GO:0044432;endoplasmic reticulum part;1.26484336649484e-06!GO:0006888;ER to Golgi vesicle-mediated transport;1.26484336649484e-06!GO:0005793;ER-Golgi intermediate compartment;1.28531790031562e-06!GO:0044440;endosomal part;1.32392907789488e-06!GO:0010008;endosome membrane;1.32392907789488e-06!GO:0016197;endosome transport;1.39005820877476e-06!GO:0007264;small GTPase mediated signal transduction;1.78915050306263e-06!GO:0032446;protein modification by small protein conjugation;1.82087737748988e-06!GO:0016568;chromatin modification;1.88411797617664e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;1.97900650260552e-06!GO:0051028;mRNA transport;2.04120398181806e-06!GO:0004386;helicase activity;2.27912817509356e-06!GO:0031982;vesicle;2.31730420737228e-06!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;2.7780161633157e-06!GO:0004298;threonine endopeptidase activity;3.1416142910413e-06!GO:0008026;ATP-dependent helicase activity;3.18715311651808e-06!GO:0016567;protein ubiquitination;3.97622701233702e-06!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;4.39466561807326e-06!GO:0032561;guanyl ribonucleotide binding;4.44953960910212e-06!GO:0019001;guanyl nucleotide binding;4.44953960910212e-06!GO:0006281;DNA repair;6.7110895376199e-06!GO:0016563;transcription activator activity;6.97255874767015e-06!GO:0006325;establishment and/or maintenance of chromatin architecture;7.08158555245899e-06!GO:0016044;membrane organization and biogenesis;7.11643546414718e-06!GO:0046930;pore complex;7.16322338047451e-06!GO:0042254;ribosome biogenesis and assembly;7.29689810968824e-06!GO:0065002;intracellular protein transport across a membrane;7.39796312600601e-06!GO:0022402;cell cycle process;7.89090379913502e-06!GO:0009966;regulation of signal transduction;1.03823973429122e-05!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;1.09991361126848e-05!GO:0015399;primary active transmembrane transporter activity;1.09991361126848e-05!GO:0042175;nuclear envelope-endoplasmic reticulum network;1.14215990430845e-05!GO:0051789;response to protein stimulus;1.42827173733574e-05!GO:0006986;response to unfolded protein;1.42827173733574e-05!GO:0005789;endoplasmic reticulum membrane;1.54866632322656e-05!GO:0031410;cytoplasmic vesicle;1.56465354759851e-05!GO:0031988;membrane-bound vesicle;1.57984705421781e-05!GO:0006323;DNA packaging;1.62263030815398e-05!GO:0043566;structure-specific DNA binding;1.64818994656467e-05!GO:0031323;regulation of cellular metabolic process;1.71089493714075e-05!GO:0005769;early endosome;1.99645553660022e-05!GO:0031252;leading edge;2.15428173267488e-05!GO:0003724;RNA helicase activity;2.27597602401577e-05!GO:0005761;mitochondrial ribosome;2.39205353126252e-05!GO:0000313;organellar ribosome;2.39205353126252e-05!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;2.56598913677361e-05!GO:0006613;cotranslational protein targeting to membrane;2.86222084371453e-05!GO:0009060;aerobic respiration;3.01223310512057e-05!GO:0008632;apoptotic program;3.17907816220596e-05!GO:0045259;proton-transporting ATP synthase complex;3.28282267182315e-05!GO:0048475;coated membrane;3.63419027972873e-05!GO:0030117;membrane coat;3.63419027972873e-05!GO:0031902;late endosome membrane;3.66013756626851e-05!GO:0003714;transcription corepressor activity;4.37014316117872e-05!GO:0030120;vesicle coat;4.87339942950486e-05!GO:0030662;coated vesicle membrane;4.87339942950486e-05!GO:0006401;RNA catabolic process;5.5650855473187e-05!GO:0016023;cytoplasmic membrane-bound vesicle;5.8650595564874e-05!GO:0003697;single-stranded DNA binding;5.96260566609895e-05!GO:0031202;RNA splicing factor activity, transesterification mechanism;5.96389785841738e-05!GO:0016772;transferase activity, transferring phosphorus-containing groups;5.98219707349989e-05!GO:0000245;spliceosome assembly;6.55668489973697e-05!GO:0051168;nuclear export;7.08657964793178e-05!GO:0030532;small nuclear ribonucleoprotein complex;7.13047831388936e-05!GO:0051427;hormone receptor binding;8.43159768666642e-05!GO:0030695;GTPase regulator activity;8.72256362123285e-05!GO:0005096;GTPase activator activity;8.72256362123285e-05!GO:0007005;mitochondrion organization and biogenesis;9.1599730019219e-05!GO:0009719;response to endogenous stimulus;9.49717382842136e-05!GO:0051276;chromosome organization and biogenesis;9.84534977519081e-05!GO:0022890;inorganic cation transmembrane transporter activity;0.000100593693267987!GO:0045333;cellular respiration;0.000101975077693541!GO:0051336;regulation of hydrolase activity;0.000102168548224876!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.000112060477152395!GO:0006818;hydrogen transport;0.000113212527317247!GO:0032940;secretion by cell;0.000126575711663912!GO:0035257;nuclear hormone receptor binding;0.00014866774457494!GO:0006897;endocytosis;0.000172451348471727!GO:0010324;membrane invagination;0.000172451348471727!GO:0046822;regulation of nucleocytoplasmic transport;0.000177686833612188!GO:0015992;proton transport;0.000178214969489578!GO:0006399;tRNA metabolic process;0.000181433410344357!GO:0045892;negative regulation of transcription, DNA-dependent;0.000191777594651904!GO:0009117;nucleotide metabolic process;0.000204089761104923!GO:0043492;ATPase activity, coupled to movement of substances;0.000207564267308177!GO:0005885;Arp2/3 protein complex;0.000215043846821895!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.000228099888111987!GO:0008234;cysteine-type peptidase activity;0.000238745736057999!GO:0005852;eukaryotic translation initiation factor 3 complex;0.000251372642813096!GO:0008186;RNA-dependent ATPase activity;0.000260918922992869!GO:0010468;regulation of gene expression;0.000260926421676802!GO:0001816;cytokine production;0.000280429444101859!GO:0007050;cell cycle arrest;0.000280429444101859!GO:0000151;ubiquitin ligase complex;0.000296189393575231!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.000297521828896267!GO:0004812;aminoacyl-tRNA ligase activity;0.000297521828896267!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.000297521828896267!GO:0046519;sphingoid metabolic process;0.000345427990251469!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.000365382906101426!GO:0001726;ruffle;0.000431232313108354!GO:0044431;Golgi apparatus part;0.00044300045905683!GO:0007034;vacuolar transport;0.000444557745063737!GO:0043038;amino acid activation;0.000446587091233713!GO:0006418;tRNA aminoacylation for protein translation;0.000446587091233713!GO:0043039;tRNA aminoacylation;0.000446587091233713!GO:0009893;positive regulation of metabolic process;0.00051642506583794!GO:0016072;rRNA metabolic process;0.00052379387321788!GO:0006402;mRNA catabolic process;0.000537037738672736!GO:0006612;protein targeting to membrane;0.000555906461547474!GO:0007040;lysosome organization and biogenesis;0.000559298974464496!GO:0006672;ceramide metabolic process;0.000593738019250089!GO:0007033;vacuole organization and biogenesis;0.000603003380206496!GO:0016740;transferase activity;0.000659998411497851!GO:0030036;actin cytoskeleton organization and biogenesis;0.000665798634832483!GO:0007041;lysosomal transport;0.000666680613611555!GO:0005083;small GTPase regulator activity;0.000669389624863802!GO:0051338;regulation of transferase activity;0.000680279836317195!GO:0006364;rRNA processing;0.000719429197840397!GO:0005798;Golgi-associated vesicle;0.00072317624583659!GO:0005057;receptor signaling protein activity;0.000751022383756838!GO:0004004;ATP-dependent RNA helicase activity;0.000762545001335517!GO:0008654;phospholipid biosynthetic process;0.000780720002808727!GO:0051223;regulation of protein transport;0.000830200937118385!GO:0016779;nucleotidyltransferase activity;0.000872828782139264!GO:0043623;cellular protein complex assembly;0.000883762131344453!GO:0006954;inflammatory response;0.00089188953683704!GO:0016251;general RNA polymerase II transcription factor activity;0.000896191315303012!GO:0005667;transcription factor complex;0.000906228610994834!GO:0004674;protein serine/threonine kinase activity;0.000908289785941374!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.000908289785941374!GO:0051187;cofactor catabolic process;0.000915100950423306!GO:0030099;myeloid cell differentiation;0.000932598480952335!GO:0046983;protein dimerization activity;0.000957489918580654!GO:0007265;Ras protein signal transduction;0.00106179980345705!GO:0006099;tricarboxylic acid cycle;0.00106179980345705!GO:0046356;acetyl-CoA catabolic process;0.00106179980345705!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0010899861408523!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00124268775821207!GO:0051090;regulation of transcription factor activity;0.0012482872062914!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0012482872062914!GO:0006643;membrane lipid metabolic process;0.00126997252251206!GO:0043085;positive regulation of catalytic activity;0.00129009025758473!GO:0033157;regulation of intracellular protein transport;0.00136546407725462!GO:0042306;regulation of protein import into nucleus;0.00136546407725462!GO:0043549;regulation of kinase activity;0.00137836648897606!GO:0005637;nuclear inner membrane;0.00138395437133359!GO:0003729;mRNA binding;0.00152035590964303!GO:0022415;viral reproductive process;0.00153091393179497!GO:0030149;sphingolipid catabolic process;0.0015714074199765!GO:0006350;transcription;0.00158810883736825!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.00162212446740177!GO:0006919;caspase activation;0.00165867018178734!GO:0043281;regulation of caspase activity;0.00174337608119656!GO:0033116;ER-Golgi intermediate compartment membrane;0.00190603881625686!GO:0043021;ribonucleoprotein binding;0.00193403233847213!GO:0031072;heat shock protein binding;0.00193896235668183!GO:0045859;regulation of protein kinase activity;0.00200226985404706!GO:0065004;protein-DNA complex assembly;0.00206723053880843!GO:0043280;positive regulation of caspase activity;0.00208857300275772!GO:0045454;cell redox homeostasis;0.00215099625365578!GO:0002757;immune response-activating signal transduction;0.00216851972960573!GO:0046966;thyroid hormone receptor binding;0.00236516219091872!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00242402439924987!GO:0006084;acetyl-CoA metabolic process;0.00263139382672871!GO:0004437;inositol or phosphatidylinositol phosphatase activity;0.00266139699467558!GO:0006352;transcription initiation;0.00274979552067744!GO:0045893;positive regulation of transcription, DNA-dependent;0.00276919451160696!GO:0031901;early endosome membrane;0.00276919451160696!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.00291377958857996!GO:0016363;nuclear matrix;0.00302358532070535!GO:0045941;positive regulation of transcription;0.00303448138078604!GO:0009109;coenzyme catabolic process;0.00316627749096013!GO:0043087;regulation of GTPase activity;0.00327142503735557!GO:0005741;mitochondrial outer membrane;0.00327142503735557!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00327142503735557!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00327142503735557!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00327142503735557!GO:0009165;nucleotide biosynthetic process;0.00327142503735557!GO:0044262;cellular carbohydrate metabolic process;0.00333144852855934!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00353648588810277!GO:0048487;beta-tubulin binding;0.00353972335191697!GO:0006091;generation of precursor metabolites and energy;0.00354457649995897!GO:0042990;regulation of transcription factor import into nucleus;0.00361875760481887!GO:0042991;transcription factor import into nucleus;0.00361875760481887!GO:0051707;response to other organism;0.00363052381371845!GO:0005813;centrosome;0.00368457294747447!GO:0003690;double-stranded DNA binding;0.00377439263239551!GO:0060090;molecular adaptor activity;0.00384767420352542!GO:0006891;intra-Golgi vesicle-mediated transport;0.00414740206867002!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00415481327564164!GO:0018193;peptidyl-amino acid modification;0.00415704324152048!GO:0045045;secretory pathway;0.00431789732250058!GO:0031325;positive regulation of cellular metabolic process;0.00434556192944718!GO:0002764;immune response-regulating signal transduction;0.004606327549579!GO:0004197;cysteine-type endopeptidase activity;0.00470376356203368!GO:0030029;actin filament-based process;0.00517114632443983!GO:0045321;leukocyte activation;0.0052206307574309!GO:0002274;myeloid leukocyte activation;0.00532932102381684!GO:0019219;regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00555335734789327!GO:0006368;RNA elongation from RNA polymerase II promoter;0.00589755071367077!GO:0019221;cytokine and chemokine mediated signaling pathway;0.00639160185287779!GO:0033367;protein localization in mast cell secretory granule;0.00647250559920841!GO:0033365;protein localization in organelle;0.00647250559920841!GO:0033371;T cell secretory granule organization and biogenesis;0.00647250559920841!GO:0033373;maintenance of protease localization in mast cell secretory granule;0.00647250559920841!GO:0033375;protease localization in T cell secretory granule;0.00647250559920841!GO:0042629;mast cell granule;0.00647250559920841!GO:0033377;maintenance of protein localization in T cell secretory granule;0.00647250559920841!GO:0033364;mast cell secretory granule organization and biogenesis;0.00647250559920841!GO:0033380;granzyme B localization in T cell secretory granule;0.00647250559920841!GO:0033379;maintenance of protease localization in T cell secretory granule;0.00647250559920841!GO:0033370;maintenance of protein localization in mast cell secretory granule;0.00647250559920841!GO:0033368;protease localization in mast cell secretory granule;0.00647250559920841!GO:0033366;protein localization in secretory granule;0.00647250559920841!GO:0033382;maintenance of granzyme B localization in T cell secretory granule;0.00647250559920841!GO:0033374;protein localization in T cell secretory granule;0.00647250559920841!GO:0045637;regulation of myeloid cell differentiation;0.00649855057131272!GO:0019904;protein domain specific binding;0.00654088271643708!GO:0048500;signal recognition particle;0.00663523157659247!GO:0005484;SNAP receptor activity;0.00667836386129146!GO:0030097;hemopoiesis;0.00673518524794825!GO:0019867;outer membrane;0.00674746760282819!GO:0005099;Ras GTPase activator activity;0.00680924929317776!GO:0031968;organelle outer membrane;0.00698599593910103!GO:0042802;identical protein binding;0.00713901478079801!GO:0043433;negative regulation of transcription factor activity;0.00716468981184665!GO:0019377;glycolipid catabolic process;0.00720880997799755!GO:0000139;Golgi membrane;0.00773377738972736!GO:0001817;regulation of cytokine production;0.00802501588866808!GO:0002429;immune response-activating cell surface receptor signaling pathway;0.0081111080707588!GO:0016773;phosphotransferase activity, alcohol group as acceptor;0.00828190283374505!GO:0006611;protein export from nucleus;0.0083471488210372!GO:0032386;regulation of intracellular transport;0.00921064933752049!GO:0004185;serine carboxypeptidase activity;0.00929451898583257!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.00981369881683941!GO:0045047;protein targeting to ER;0.00981369881683941!GO:0006665;sphingolipid metabolic process;0.0102067578871733!GO:0019079;viral genome replication;0.0103387250602945!GO:0008383;manganese superoxide dismutase activity;0.0106647410355116!GO:0001315;age-dependent response to reactive oxygen species;0.0106647410355116!GO:0016791;phosphoric monoester hydrolase activity;0.0109874290261244!GO:0005815;microtubule organizing center;0.0111944631914528!GO:0006952;defense response;0.0113955435892502!GO:0002504;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;0.0117336625285286!GO:0000339;RNA cap binding;0.012078548179244!GO:0006458;'de novo' protein folding;0.0125050488314613!GO:0051084;'de novo' posttranslational protein folding;0.0125050488314613!GO:0007259;JAK-STAT cascade;0.012685078043021!GO:0046479;glycosphingolipid catabolic process;0.0127845069407736!GO:0030134;ER to Golgi transport vesicle;0.0128007942010742!GO:0031625;ubiquitin protein ligase binding;0.0131671108229918!GO:0016301;kinase activity;0.0138320740144984!GO:0006607;NLS-bearing substrate import into nucleus;0.013836259924634!GO:0048471;perinuclear region of cytoplasm;0.0139908676164219!GO:0051252;regulation of RNA metabolic process;0.0140335566409243!GO:0046467;membrane lipid biosynthetic process;0.0142226106056645!GO:0030041;actin filament polymerization;0.0146570084989533!GO:0005048;signal sequence binding;0.0148960385024836!GO:0030127;COPII vesicle coat;0.0148960385024836!GO:0012507;ER to Golgi transport vesicle membrane;0.0148960385024836!GO:0008312;7S RNA binding;0.0149018471134027!GO:0000209;protein polyubiquitination;0.0151544382504461!GO:0050811;GABA receptor binding;0.0151772406243682!GO:0000278;mitotic cell cycle;0.0152626197173652!GO:0006367;transcription initiation from RNA polymerase II promoter;0.0156379017244714!GO:0051345;positive regulation of hydrolase activity;0.0159395834929514!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0159435981958487!GO:0001819;positive regulation of cytokine production;0.0162737587520453!GO:0002768;immune response-regulating cell surface receptor signaling pathway;0.0163348253823419!GO:0043022;ribosome binding;0.016645710820584!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0169201469795554!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0169201469795554!GO:0006749;glutathione metabolic process;0.0170669506987089!GO:0000082;G1/S transition of mitotic cell cycle;0.0178582509433892!GO:0004177;aminopeptidase activity;0.0179816146405587!GO:0051098;regulation of binding;0.018333953695805!GO:0019843;rRNA binding;0.0186628611299639!GO:0000287;magnesium ion binding;0.0187030106865543!GO:0008270;zinc ion binding;0.0187138587553914!GO:0030663;COPI coated vesicle membrane;0.0187798462994253!GO:0030126;COPI vesicle coat;0.0187798462994253!GO:0043621;protein self-association;0.0192753313949063!GO:0030521;androgen receptor signaling pathway;0.0193275538735727!GO:0006333;chromatin assembly or disassembly;0.0196678786386579!GO:0030503;regulation of cell redox homeostasis;0.0196678786386579!GO:0005694;chromosome;0.0196678786386579!GO:0006414;translational elongation;0.0196727260712166!GO:0008637;apoptotic mitochondrial changes;0.0200744166811106!GO:0008624;induction of apoptosis by extracellular signals;0.020358699096296!GO:0002822;regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains.;0.020358699096296!GO:0002819;regulation of adaptive immune response;0.020358699096296!GO:0033033;negative regulation of myeloid cell apoptosis;0.020358699096296!GO:0001803;regulation of type III hypersensitivity;0.020358699096296!GO:0032733;positive regulation of interleukin-10 production;0.020358699096296!GO:0033025;regulation of mast cell apoptosis;0.020358699096296!GO:0001805;positive regulation of type III hypersensitivity;0.020358699096296!GO:0033023;mast cell homeostasis;0.020358699096296!GO:0002431;Fc receptor mediated stimulatory signaling pathway;0.020358699096296!GO:0033032;regulation of myeloid cell apoptosis;0.020358699096296!GO:0001802;type III hypersensitivity;0.020358699096296!GO:0033028;myeloid cell apoptosis;0.020358699096296!GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;0.020358699096296!GO:0033026;negative regulation of mast cell apoptosis;0.020358699096296!GO:0033024;mast cell apoptosis;0.020358699096296!GO:0006354;RNA elongation;0.020358699096296!GO:0030258;lipid modification;0.020358699096296!GO:0046466;membrane lipid catabolic process;0.0203742188054535!GO:0051092;activation of NF-kappaB transcription factor;0.0208126116866096!GO:0030658;transport vesicle membrane;0.0208972530000085!GO:0051087;chaperone binding;0.0208972530000085!GO:0008139;nuclear localization sequence binding;0.0210048067249992!GO:0032763;regulation of mast cell cytokine production;0.0210929539959834!GO:0032762;mast cell cytokine production;0.0210929539959834!GO:0003725;double-stranded RNA binding;0.0220565853112877!GO:0002521;leukocyte differentiation;0.0227626976423991!GO:0003711;transcription elongation regulator activity;0.0231218164899055!GO:0002763;positive regulation of myeloid leukocyte differentiation;0.0232870554976748!GO:0046483;heterocycle metabolic process;0.0236922857665483!GO:0043681;protein import into mitochondrion;0.0237150186679147!GO:0048146;positive regulation of fibroblast proliferation;0.0237979771689488!GO:0006516;glycoprotein catabolic process;0.0239582227856453!GO:0000049;tRNA binding;0.0239582227856453!GO:0006468;protein amino acid phosphorylation;0.0243619167469541!GO:0015036;disulfide oxidoreductase activity;0.0246602351438392!GO:0019058;viral infectious cycle;0.0248857509058049!GO:0006405;RNA export from nucleus;0.0250214325687399!GO:0016272;prefoldin complex;0.0250214325687399!GO:0042110;T cell activation;0.0251578516014086!GO:0032318;regulation of Ras GTPase activity;0.0251861916367801!GO:0030137;COPI-coated vesicle;0.0260257669224134!GO:0019882;antigen processing and presentation;0.0260741058578089!GO:0006260;DNA replication;0.0265574197191589!GO:0030867;rough endoplasmic reticulum membrane;0.0267265787489068!GO:0051101;regulation of DNA binding;0.0267265787489068!GO:0030518;steroid hormone receptor signaling pathway;0.0268579865813496!GO:0045449;regulation of transcription;0.0270265254058509!GO:0005669;transcription factor TFIID complex;0.0271051555721471!GO:0005070;SH3/SH2 adaptor activity;0.0271051555721471!GO:0051059;NF-kappaB binding;0.0276563329324855!GO:0006650;glycerophospholipid metabolic process;0.0277417416261062!GO:0006351;transcription, DNA-dependent;0.0277492553876158!GO:0000785;chromatin;0.0277492553876158!GO:0006626;protein targeting to mitochondrion;0.0277492553876158!GO:0030176;integral to endoplasmic reticulum membrane;0.028012408406288!GO:0032774;RNA biosynthetic process;0.0282485153075377!GO:0008320;protein transmembrane transporter activity;0.0287431055481519!GO:0051045;negative regulation of membrane protein ectodomain proteolysis;0.0291648020154807!GO:0051043;regulation of membrane protein ectodomain proteolysis;0.0291648020154807!GO:0045576;mast cell activation;0.0300566665308734!GO:0050851;antigen receptor-mediated signaling pathway;0.0302072875915177!GO:0006914;autophagy;0.0303769326022752!GO:0008538;proteasome activator activity;0.0309260625645915!GO:0002440;production of molecular mediator of immune response;0.0309260625645915!GO:0007006;mitochondrial membrane organization and biogenesis;0.0309353850507109!GO:0035035;histone acetyltransferase binding;0.0309493256546599!GO:0051052;regulation of DNA metabolic process;0.0311195037700537!GO:0030384;phosphoinositide metabolic process;0.0311195037700537!GO:0002444;myeloid leukocyte mediated immunity;0.0311195037700537!GO:0004722;protein serine/threonine phosphatase activity;0.0312419534916744!GO:0042348;NF-kappaB import into nucleus;0.0313413525622171!GO:0042345;regulation of NF-kappaB import into nucleus;0.0313413525622171!GO:0030027;lamellipodium;0.0318045056775605!GO:0006302;double-strand break repair;0.0319343449271503!GO:0030218;erythrocyte differentiation;0.0319394221315211!GO:0000119;mediator complex;0.0324269492582789!GO:0005149;interleukin-1 receptor binding;0.0326335220693053!GO:0000738;DNA catabolic process, exonucleolytic;0.0329052618762348!GO:0006383;transcription from RNA polymerase III promoter;0.0329406011589314!GO:0051085;chaperone cofactor-dependent protein folding;0.0335734887469148!GO:0046914;transition metal ion binding;0.0338172242193114!GO:0048144;fibroblast proliferation;0.0338172242193114!GO:0048145;regulation of fibroblast proliferation;0.0338172242193114!GO:0002467;germinal center formation;0.0343855439405625!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0345397306439623!GO:0000184;mRNA catabolic process, nonsense-mediated decay;0.0345397306439623!GO:0030660;Golgi-associated vesicle membrane;0.0351576576012461!GO:0002224;toll-like receptor signaling pathway;0.0357547126588118!GO:0002221;pattern recognition receptor signaling pathway;0.0357547126588118!GO:0032760;positive regulation of tumor necrosis factor production;0.0357547126588118!GO:0009306;protein secretion;0.0357573582830002!GO:0008333;endosome to lysosome transport;0.0358630122015811!GO:0042613;MHC class II protein complex;0.035901168001826!GO:0051540;metal cluster binding;0.035901168001826!GO:0051536;iron-sulfur cluster binding;0.035901168001826!GO:0030433;ER-associated protein catabolic process;0.0360215417518635!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0360215417518635!GO:0019318;hexose metabolic process;0.0364851384747653!GO:0005869;dynactin complex;0.0365493148832468!GO:0043488;regulation of mRNA stability;0.0373193041242304!GO:0043487;regulation of RNA stability;0.0373193041242304!GO:0002718;regulation of cytokine production during immune response;0.0374372452245453!GO:0002367;cytokine production during immune response;0.0374372452245453!GO:0002700;regulation of production of molecular mediator of immune response;0.0374372452245453!GO:0005850;eukaryotic translation initiation factor 2 complex;0.0375943992769575!GO:0030118;clathrin coat;0.0378507354886224!GO:0046649;lymphocyte activation;0.0381932578744167!GO:0016491;oxidoreductase activity;0.0382144724802812!GO:0006644;phospholipid metabolic process;0.0386247424176006!GO:0008625;induction of apoptosis via death domain receptors;0.0390724336398571!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0395976740253463!GO:0015002;heme-copper terminal oxidase activity;0.0395976740253463!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0395976740253463!GO:0004129;cytochrome-c oxidase activity;0.0395976740253463!GO:0045113;regulation of integrin biosynthetic process;0.0397398256470482!GO:0045112;integrin biosynthetic process;0.0397398256470482!GO:0043300;regulation of leukocyte degranulation;0.0399527103154311!GO:0006839;mitochondrial transport;0.0399760280564038!GO:0019220;regulation of phosphate metabolic process;0.0400976755506965!GO:0051174;regulation of phosphorus metabolic process;0.0400976755506965!GO:0016311;dephosphorylation;0.0405622950808849!GO:0006984;ER-nuclear signaling pathway;0.0406328757141659!GO:0045792;negative regulation of cell size;0.0407682990986018!GO:0005762;mitochondrial large ribosomal subunit;0.0414058034247952!GO:0000315;organellar large ribosomal subunit;0.0414058034247952!GO:0017091;AU-rich element binding;0.0414058034247952!GO:0050779;RNA destabilization;0.0414058034247952!GO:0000289;poly(A) tail shortening;0.0414058034247952!GO:0030133;transport vesicle;0.0419379258699959!GO:0048002;antigen processing and presentation of peptide antigen;0.0420081046525519!GO:0006689;ganglioside catabolic process;0.0420081046525519!GO:0005996;monosaccharide metabolic process;0.0424290617897206!GO:0022884;macromolecule transmembrane transporter activity;0.0427736073896433!GO:0015450;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;0.0427736073896433!GO:0045920;negative regulation of exocytosis;0.042964998245625!GO:0043301;negative regulation of leukocyte degranulation;0.042964998245625!GO:0043305;negative regulation of mast cell degranulation;0.042964998245625!GO:0051091;positive regulation of transcription factor activity;0.042964998245625!GO:0003746;translation elongation factor activity;0.0431495077662997!GO:0042147;retrograde transport, endosome to Golgi;0.0440375777305886!GO:0006007;glucose catabolic process;0.0441453283600339!GO:0009611;response to wounding;0.0443789837739108!GO:0006310;DNA recombination;0.0443789837739108!GO:0003988;acetyl-CoA C-acyltransferase activity;0.044756838939295!GO:0051235;maintenance of localization;0.0449821150620141!GO:0019883;antigen processing and presentation of endogenous antigen;0.0450691440121532!GO:0008286;insulin receptor signaling pathway;0.0454732385047804!GO:0005152;interleukin-1 receptor antagonist activity;0.0454907509697988!GO:0030353;fibroblast growth factor receptor antagonist activity;0.0454907509697988!GO:0002520;immune system development;0.0460153832630229!GO:0002252;immune effector process;0.0460153832630229!GO:0006376;mRNA splice site selection;0.0460153832630229!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0460153832630229!GO:0000118;histone deacetylase complex;0.0464387919831379!GO:0006509;membrane protein ectodomain proteolysis;0.0470659451425871!GO:0033619;membrane protein proteolysis;0.0470659451425871!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.0481723274933218!GO:0009299;mRNA transcription;0.0481927390996521!GO:0001775;cell activation;0.048432577564329!GO:0002824;positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.0487480407759694!GO:0002821;positive regulation of adaptive immune response;0.0487480407759694!GO:0017166;vinculin binding;0.0497064388056175!GO:0019783;small conjugating protein-specific protease activity;0.0499261413998873!GO:0015923;mannosidase activity;0.0499261413998873!GO:0030374;ligand-dependent nuclear receptor transcription coactivator activity;0.0499261413998873!GO:0002250;adaptive immune response;0.0499261413998873!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.0499261413998873 | |||
|sample_id=11887 | |sample_id=11887 | ||
|sample_note= | |sample_note= |
Revision as of 17:11, 25 June 2012
Name: | CD14+ monocytes - treated with Cryptococcus, donor3 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs13546
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs13546
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.0877 |
10 | 10 | 0.021 |
100 | 100 | 0.761 |
101 | 101 | 0.971 |
102 | 102 | 0.786 |
103 | 103 | 0.229 |
104 | 104 | 0.577 |
105 | 105 | 0.185 |
106 | 106 | 0.00216 |
107 | 107 | 0.321 |
108 | 108 | 0.762 |
109 | 109 | 0.194 |
11 | 11 | 0.145 |
110 | 110 | 0.201 |
111 | 111 | 0.0638 |
112 | 112 | 0.316 |
113 | 113 | 0.554 |
114 | 114 | 0.0196 |
115 | 115 | 0.122 |
116 | 116 | 0.85 |
117 | 117 | 0.0577 |
118 | 118 | 0.184 |
119 | 119 | 0.148 |
12 | 12 | 0.304 |
120 | 120 | 0.361 |
121 | 121 | 0.472 |
122 | 122 | 0.588 |
123 | 123 | 0.44 |
124 | 124 | 0.715 |
125 | 125 | 0.428 |
126 | 126 | 0.172 |
127 | 127 | 0.362 |
128 | 128 | 0.0445 |
129 | 129 | 0.373 |
13 | 13 | 0.127 |
130 | 130 | 0.378 |
131 | 131 | 0.691 |
132 | 132 | 0.0603 |
133 | 133 | 0.964 |
134 | 134 | 0.539 |
135 | 135 | 0.305 |
136 | 136 | 0.89 |
137 | 137 | 0.00743 |
138 | 138 | 0.347 |
139 | 139 | 0.0474 |
14 | 14 | 0.583 |
140 | 140 | 0.216 |
141 | 141 | 0.309 |
142 | 142 | 0.516 |
143 | 143 | 0.0164 |
144 | 144 | 0.622 |
145 | 145 | 0.535 |
146 | 146 | 0.606 |
147 | 147 | 0.524 |
148 | 148 | 0.0185 |
149 | 149 | 0.837 |
15 | 15 | 0.14 |
150 | 150 | 0.496 |
151 | 151 | 0.425 |
152 | 152 | 0.241 |
153 | 153 | 0.504 |
154 | 154 | 0.76 |
155 | 155 | 0.706 |
156 | 156 | 0.517 |
157 | 157 | 0.562 |
158 | 158 | 0.0562 |
159 | 159 | 0.116 |
16 | 16 | 0.317 |
160 | 160 | 0.523 |
161 | 161 | 0.47 |
162 | 162 | 0.226 |
163 | 163 | 0.25 |
164 | 164 | 0.151 |
165 | 165 | 0.164 |
166 | 166 | 0.584 |
167 | 167 | 0.23 |
168 | 168 | 0.15 |
169 | 169 | 0.00779 |
17 | 17 | 0.242 |
18 | 18 | 0.123 |
19 | 19 | 0.342 |
2 | 2 | 0.744 |
20 | 20 | 0.318 |
21 | 21 | 0.614 |
22 | 22 | 0.231 |
23 | 23 | 0.0647 |
24 | 24 | 0.304 |
25 | 25 | 0.308 |
26 | 26 | 0.0504 |
27 | 27 | 0.856 |
28 | 28 | 0.388 |
29 | 29 | 0.272 |
3 | 3 | 0.143 |
30 | 30 | 0.523 |
31 | 31 | 0.79 |
32 | 32 | 0.618 |
33 | 33 | 0.282 |
34 | 34 | 0.579 |
35 | 35 | 0.137 |
36 | 36 | 0.0987 |
37 | 37 | 0.0634 |
38 | 38 | 0.365 |
39 | 39 | 0.789 |
4 | 4 | 0.817 |
40 | 40 | 0.202 |
41 | 41 | 0.0104 |
42 | 42 | 0.371 |
43 | 43 | 0.0321 |
44 | 44 | 0.934 |
45 | 45 | 0.7 |
46 | 46 | 0.164 |
47 | 47 | 0.477 |
48 | 48 | 0.464 |
49 | 49 | 0.126 |
5 | 5 | 0.236 |
50 | 50 | 0.913 |
51 | 51 | 0.412 |
52 | 52 | 0.373 |
53 | 53 | 0.453 |
54 | 54 | 0.356 |
55 | 55 | 0.63 |
56 | 56 | 0.712 |
57 | 57 | 0.928 |
58 | 58 | 0.125 |
59 | 59 | 0.178 |
6 | 6 | 0.619 |
60 | 60 | 0.0512 |
61 | 61 | 0.571 |
62 | 62 | 0.0532 |
63 | 63 | 0.566 |
64 | 64 | 0.437 |
65 | 65 | 0.233 |
66 | 66 | 0.41 |
67 | 67 | 0.395 |
68 | 68 | 0.553 |
69 | 69 | 0.633 |
7 | 7 | 0.22 |
70 | 70 | 0.0325 |
71 | 71 | 0.0218 |
72 | 72 | 0.257 |
73 | 73 | 0.148 |
74 | 74 | 0.0721 |
75 | 75 | 0.0884 |
76 | 76 | 0.204 |
77 | 77 | 0.483 |
78 | 78 | 0.131 |
79 | 79 | 0.764 |
8 | 8 | 0.4 |
80 | 80 | 0.101 |
81 | 81 | 0.34 |
82 | 82 | 0.141 |
83 | 83 | 0.0612 |
84 | 84 | 0.401 |
85 | 85 | 0.0221 |
86 | 86 | 0.058 |
87 | 87 | 0.294 |
88 | 88 | 0.628 |
89 | 89 | 0.166 |
9 | 9 | 0.366 |
90 | 90 | 0.085 |
91 | 91 | 0.362 |
92 | 92 | 0.208 |
93 | 93 | 0.173 |
94 | 94 | 0.0465 |
95 | 95 | 0.369 |
96 | 96 | 0.392 |
97 | 97 | 0.786 |
98 | 98 | 0.149 |
99 | 99 | 0.0743 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs13546
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000210 human sample
FF:0011105 human CD14-positive monocytes - treated with Cryptococcus sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000988 (hematopoietic cell)
0000839 (myeloid lineage restricted progenitor cell)
0000548 (animal cell)
0002194 (monopoietic cell)
0000034 (stem cell)
0002032 (hematopoietic oligopotent progenitor cell)
0000763 (myeloid cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
0000766 (myeloid leukocyte)
0000219 (motile cell)
0000134 (mesenchymal cell)
0000738 (leukocyte)
0002087 (nongranular leukocyte)
0000255 (eukaryotic cell)
0002031 (hematopoietic lineage restricted progenitor cell)
0000576 (monocyte)
0000037 (hematopoietic stem cell)
0000860 (classical monocyte)
0000566 (angioblastic mesenchymal cell)
0000049 (common myeloid progenitor)
0000557 (granulocyte monocyte progenitor cell)
0000837 (hematopoietic multipotent progenitor cell)
0002057 (CD14-positive, CD16-negative classical monocyte)
0002009 (macrophage dendritic cell progenitor)
0000040 (monoblast)
0000559 (promonocyte)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000922 (embryo)
0002371 (bone marrow)
0001474 (bone element)
0002384 (connective tissue)
0000926 (mesoderm)
0000479 (tissue)
0000062 (organ)
0004765 (skeletal element)
0004120 (mesoderm-derived structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0002050 (embryonic structure)
0005423 (developing anatomical structure)
0000467 (anatomical system)
0001062 (anatomical entity)
0005291 (embryonic tissue)
0006598 (presumptive structure)
0002532 (epiblast (generic))
0002204 (musculoskeletal system)
0001434 (skeletal system)
0002390 (hematopoietic system)
0002193 (hemolymphoid system)
0002405 (immune system)
0003081 (lateral plate mesoderm)
0006603 (presumptive mesoderm)
0003061 (blood island)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA